ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in ESSA Pharma Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
EPIX is no longer listed, so this page shows Q3 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 32
- −4 vs. Q2 2025
- Shares held
- 22.5M
- −8.45M (−27.3%) vs. Q2 2025
- Total value
- $4.30M
- −$48.3M (−91.8%) vs. Q2 2025
- New holders
- 8
- 8 more added
- Sold out
- 12
- 8 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 16 | $3 | 0.00% | +16 | New |
| JPMorgan Chase & Co | 21 | $4 | 0.00% | −189,073−100.0% | Reduced |
| Barclays PLC | 355 | $68 | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 490 | $94 | 0.00% | −3,198−86.7% | Reduced |
| TD Waterhouse Canada Inc. | 900 | $185 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 2,050 | $392 | 0.00% | −2,000−49.4% | Reduced |
| CIBC Private Wealth Group, LLC | 2,500 | $478 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,473 | $1.05K | 0.00% | −6,548−54.5% | Reduced |
| BlackRock, Inc. | 7,074 | $1.35K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,000 | $1.44K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 9,800 | $1.87K | 0.00% | −261,395−96.4% | Reduced |
| Belvedere Trading LLC | 15,201 | $2.90K | 0.00% | +15,201 | New |
| Simplex Trading, LLC | 20,381 | $3.00K | 0.00% | +20,381 | New |
| Royal Bank of Canada | 19,831 | $4.00K | 0.00% | +19,014+2,327.3% | Added |
| Geode Capital Management, LLC | 23,840 | $4.55K | 0.00% | 00.0% | Unchanged |
| Beaumont Capital Management, LLC | 28,225 | $5.39K | 0.00% | +28,225 | New |
| XTX Topco Ltd | 45,524 | $8.70K | 0.00% | +3,351+7.9% | Added |
| Skandinaviska Enskilda Banken AB (publ) | 51,973 | $9.93K | 0.00% | +51,973 | New |
| Magnus Financial Group LLC | 55,206 | $10.5K | 0.00% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 72,123 | $13.8K | 0.01% | +72,123 | New |
| Virtu Financial LLC | 77,036 | $15.0K | 0.00% | +77,036 | New |
| CSS LLC | 103,488 | $19.8K | 0.00% | +103,488 | New |
| Citadel Advisors LLC | 144,449 | $27.6K | 0.00% | +90,410+167.3% | Added |
| Two Sigma Advisers, LP | 214,800 | $41.0K | 0.00% | −46,000−17.6% | Reduced |
| Two Sigma Investments, LP | 336,164 | $64.2K | 0.00% | +113,837+51.2% | Added |
| Shay Capital LLC | 536,533 | $102.5K | 0.02% | +512,185+2,103.6% | Added |
| LMR Partners LLP | 540,984 | $103.3K | 0.00% | +340,984+170.5% | Added |
| Bank of America Corp | 591,834 | $113.0K | 0.00% | −36,096−5.7% | Reduced |
| Pfizer Inc | 1,675,000 | $319.9K | 0.07% | 00.0% | Unchanged |
| Morgan Stanley | 1,904,061 | $363.7K | 0.00% | −2,305,609−54.8% | Reduced |
| Soleus Capital Management, L.P. | 4,362,026 | $833.1K | 0.04% | +2,100,000+92.8% | Added |
| BVF Inc | 11,668,473 | $2.23M | 0.09% | +2,919,844+33.4% | Added |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −4,300,000−100.0% | Sold out |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −4,221,546−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −2,209,998−100.0% | Sold out |
| Aldebaran Capital, LLC | 0 | $0 | 0.00% | −578,939−100.0% | Sold out |
| DLD Asset Management, LP | 0 | $0 | 0.00% | −314,968−100.0% | Sold out |
| Rangeley Capital, LLC | 0 | $0 | 0.00% | −170,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −83,823−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −46,373−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −43,907−100.0% | Sold out |
| Lepercq De Neuflize Asset Management LLC | 0 | $0 | 0.00% | −33,700−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −14,343−100.0% | Sold out |